Skip to main navigation Skip to search Skip to main content

Recurrent moderate hypoglycemia accelerates the progression of Alzheimer's disease through impairment of the TRPC6/GLUT3 pathway

  • Chengkang He
  • , Qiang Li
  • , Yuanting Cui
  • , Peng Gao
  • , Wentao Shu
  • , Qing Zhou
  • , Lijuan Wang
  • , Li Li
  • , Zongshi Lu
  • , Yu Zhao
  • , Huan Ma
  • , Xiaowei Chen
  • , Hongbo Jia
  • , Hongting Zheng
  • , Gangyi Yang
  • , Daoyan Liu
  • , Martin Tepel
  • , Zhiming Zhu*
  • *Corresponding author for this work
  • Chinese Academy of Sciences
  • Chongqing Medical University
  • Army Medical University

Research output: Contribution to journal › Journal article › Research › peer-review

102 Downloads (Pure)

Abstract

Currently, the most effective strategy for dealing with Alzheimer's disease (AD) is delaying the onset of dementia. Severe hypoglycemia is strongly associated with dementia; however, the effects of recurrent moderate hypoglycemia (RH) on the progression of cognitive deficits in patients with diabetes with genetic susceptibility to AD remain unclear. Here, we report that insulin-controlled hyperglycemia slightly aggravated AD-type pathologies and cognitive impairment; however, RH significantly increased neuronal hyperactivity and accelerated the progression of cognitive deficits in streptozotocin-induced (STZ-induced) diabetic APP/PS1 mice. Glucose transporter 3-mediated (GLUT3-mediated) neuronal glucose uptake was not significantly altered under hyperglycemia but was markedly reduced by RH, which induced excessive mitochondrial fission in the hippocampus. Overexpression of GLUT3, specifically in the dentate gyrus (DG) area of the hippocampus, enhanced mitochondrial function and improved cognitive deficits. Activation of the transient receptor potential channel 6 (TRPC6) increased GLUT3-mediated glucose uptake in the brain and alleviated RH-induced cognitive deficits, and inactivation of the Ca2+/AMPK pathway was responsible for TRPC6-induced GLUT3 inhibition. Taken together, RH impairs brain GLUT3-mediated glucose uptake and further provokes neuronal mitochondrial dysfunction by inhibiting TRPC6 expression, which then accelerates progression of cognitive deficits in diabetic APP/PS1 mice. Avoiding RH is essential for glycemic control in patients with diabetes, and TRPC6/GLUT3 represents potent targets for delaying the onset of dementia in patients with diabetes.

Original languageEnglish
Article numbere154595
JournalJCI Insight
Volume7
Issue number5
Number of pages17
ISSN2379-3708
DOIs
Publication statusPublished - 8. Mar 2022

Bibliographical note

Publisher Copyright:
© 2022, He et al.

Funding

This study was supported by grant 81721001 from the Funds for Creative Research Groups of China, the Major International (Regional) Joint Research Project 81920108010 of China, and grants 81900761, 81770416, and 81670382 of the National Natural Science Foundation of China. The funders had no role in the design or conduct of the study; in the collection, management, analysis, or interpretation of the data; nor in the preparation, review, or approval of the manuscript.

Keywords

  • Alzheimer Disease/pathology
  • Animals
  • Glucose/metabolism
  • Glucose Transporter Type 3
  • Hyperglycemia
  • Hypoglycemia/complications
  • Insulin/metabolism
  • Mice
  • Mice, Transgenic
  • TRPC6 Cation Channel
  • Transient Receptor Potential Channels

Fingerprint

Dive into the research topics of 'Recurrent moderate hypoglycemia accelerates the progression of Alzheimer's disease through impairment of the TRPC6/GLUT3 pathway'. Together they form a unique fingerprint.

Cite this